Audrey M.
- Country
- France
- Department
- Oncologie
Research Overview
- Phase 3 Randomized Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in HR+/HER2- Metastatic Breast Cancer
- Evaluation of Oocyte/Embryo Cryopreservation Efficacy in Young Breast Cancer Patients Undergoing Adjuvant Chemotherapy with Follitropin Alfa and Follitropin Beta
- Phase II Trial of Durvalumab, Olaparib, and Fulvestrant in ER-Positive, HER2-Negative Metastatic Breast Cancer with BRCA or HRR Gene Alterations
Data & Insights
Has run more than one trial at 163 of 472 partner sites.
Specializations
Early-Stage Breast Cancer
The investigator specializes in treating hormone receptor-positive (ER+) and HER2-negative breast cancer, with particular focus on high-risk cases requiring adjuvant therapy. Their research explores alternatives to traditional chemotherapy, including targeted endocrine treatments.
- Adjuvant Hormone Therapy
- Disease-Free Survival Optimization
- Risk Reduction Strategies
Advanced Breast Cancer Treatment
Expertise in managing metastatic breast cancer through innovative therapeutic combinations. The investigator focuses on developing treatment strategies for patients with hormone receptor-positive advanced disease and exploring novel drug combinations.
- Targeted Therapy Development
- Combination Treatment Approaches
- Drug Resistance Management
Specialized Patient Populations
The investigator addresses specific needs of distinct breast cancer patient groups, including young women with fertility concerns and older patients requiring personalized treatment approaches. Their work encompasses fertility preservation strategies and age-appropriate therapeutic interventions.
- Fertility Preservation
- Age-Specific Treatment Protocols
- Quality of Life Considerations
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.